Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp.

International Journal of Antimicrobial Agents

Volumn 31, Issue 4, 2008, Pages 321-328

  Roveta, S ^a   Marchese, A ^a   Schito, G C ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Lipopeptide; Slime; Staphylococci

Indexed keywords

DAPTOMYCIN; POLYSTYRENE;

ARTICLE; BIOFILM; CONTROLLED STUDY; DRUG ACTIVITY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; SPECTROPHOTOMETRY; STAPHYLOCOCCUS; STAPHYLOCOCCUS EPIDERMIDIS; STATISTICAL SIGNIFICANCE;

ANTI-BACTERIAL AGENTS; BIOFILMS; COLONY COUNT, MICROBIAL; DAPTOMYCIN; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; PLASTICS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 40849094423     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.11.012     Document Type: Article

References (39)

1. Darouiche R.O. Treatment of infections associated with surgical implants. N Engl J Med 350 (2004) 1422-1429
2. Vinh D.C., and Embil J.M. Device-related infections: a review. J Long Term Eff Med Implants 15 (2005) 467-488
3. Edmiston Jr. C.E., Goheen M.P., Seabrook G.R., Johnson C.P., Lewis B.D., Brown K.R., et al. Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices. Am J Surg 192 (2006) 344-354
4. Mack D., Rohde H., Harris L.G., Davies A.P., Horstkotte M.A., and Knobloch J.K. Biofilm formation in medical device-related infection. Int J Artif Organs 29 (2006) 343-359
5. Donlan R.M., and Costerton W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15 (2002) 167-193
6. Dunne W.M. Bacterial adhesion: seen any good biofilms lately?. Clin Microbiol Rev 15 (2002) 155-166
7. Prince A.S. Biofilms, antimicrobial resistance, and airway infection. N Engl J Med 347 (2002) 1110-1111
8. von Eiff C., Jansen B., Kohnen W., and Becker K. Infections associated with medical devices: pathogenesis, management and prophylaxis. Drugs 65 (2005) 179-214
9. O'Gara J.P., and Humphreys H. Staphylococcus epidermidis biofilms: importance and implications. J Med Microbiol 50 (2001) 582-587
10. Mack D., Becker P., Chatterjee I., Dobinsky S., Knobloch J.K., Peters G., et al. Mechanisms of biofilm formation in Staphylococcus epidermidis and Staphylococcus aureus: functional molecules, regulatory circuits, and adaptive responses. Int J Med Microbiol. 294 (2004) 203-212
11. Gander S., Kinnaird A., and Finch R. Telavancin: in vitro activity against staphylococci in a biofilm model. J Antimicrob Chemother 5 (2005) 337-343
12. Kanafani Z.A. Telavancin: a new lipoglycopeptide with multiple mechanisms of action. Expert Rev Anti Infect Ther 4 (2006) 743-749
13. Higgins D.L., Chang R., Debabov D.V., Leung J., Wu T., Krause K.M., et al. Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 49 (2005) 1127-1134
14. Silverman J.A., Perlmutter N.G., and Shapiro H.M. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob Agents Chemother 47 (2003) 2538-2544
15. Raad I.I., Hanna H.A., Boktour M., Chaiban G., Hachem R.Y., Dvorak T., et al. Vancomycin-resistant Enterococcus faecium: catheter colonization, esp gene, and decreased susceptibility to antibiotics in biofilm. Antimicrob Agents Chemother 49 (2005) 5046-5050
16. Roveta S., Schito A.M., Marchese A., and Schito G.C. Activity of moxifloxacin on biofilms produced in vitro by pathogens involved in acute bacterial exacerbations of chronic bronchitis. Int J Antimicrob Agents 30 (2007) 415-421
17. Murray P.R., Baron E.J., Jorgensen J.H., Pfaller M.A., and Yolken R.H. Manual of clinical microbiology. 8th ed. (2003), ASM Press, Washington, DC
18. Freeman D.J., Falkiner F.R., and Keane C.T. New method for detecting slime production by coagulase-negative staphylococci. J Clin Pathol 42 (1989) 872-874
19. Marchese A., Balistreri G., Tonoli E., Debbia E.A., and Schito G.C. Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital. J Clin Microbiol 38 (2000) 866-869
20. Benvenuto M., Benziger D.P., Yankelev S., and Vigliani G. Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers. Antimicrob Agents Chemother 50 (2006) 3245-3249
21. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Sixteenth informational supplement. M100-S16. Wayne, PA: CLSI; 2006.
22. Cramton S.E., Gerke C., and Catz F. In vitro methods to study biofilm formation. Methods Enzymol 336 (2001) 239-255
23. Marchese A., Bozzolasco M., Gualco L., Debbia E.A., Schito G.C., and Schito A.M. Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms. Int J Antimicrob Agents 22 Suppl. 2 (2003) 95-100
24. Stewart P.S. New ways to stop biofilm infections. Lancet. 361 (2003) 97
25. Di Bonaventura G., Spedicato I., D'Antonio D., Robuffo I., and Piccolomini R. Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime. Antimicrob Agents Chemother 48 (2004) 151-160
26. Tateda K., Standiford T.J., Pechere J.C., and Yamaguchi K. Regulatory effects of macrolides on bacterial virulence: potential role as quorum-sensing inhibitors. Curr Pharm Des 10 (2004) 3055-3065
27. Wozniak D.J., and Keyser R. Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa. Chest 125 (2004) (suppl. 2): 62S-9S
28. Cerca N., Martins S., Sillankorva S., Jefferson K.K., Pier G.B., Oliveira R., et al. Effects of growth in the presence of subinhibitory concentrations of dicloxacillin on Staphylococcus epidermidis and Staphylococcus haemolyticus biofilms. Appl Environ Microbiol 71 (2005) 8677-8682
29. Cerca N., Martins S., Cerca F., Jefferson K.K., Pier G.B., Oliveira R., et al. Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J Antimicrob Chemother 56 (2005) 331-336
30. Steenbergen J.N., Alder J., Thorne G.M., and Tally F.P. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. J Antimicrob Chemother 55 (2005) 283-288
31. Fuchs P.C., Barry A.L., and Brown S.D. In vitro bacterial activity of daptomycin against staphylococci. J Antimicrob Chemother 49 (2002) 467-470
32. French G.L. Bactericidal agents in the treatment of MRSA infections: the potential role of daptomycin. J Antimicrob Chemother 58 (2006) 1107-1117
33. Martone W.J., and Lamp K.C. Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and -resistant Staphylococcus aureus: results from the CORE Registry. Curr Med Res Opin 22 (2006) 2337-2343
34. Baltch A.L., Ritz W.J., Bopp L.H., Michelsen P.B., and Smith R.P. Antimicrobial activity of daptomycin, vancomycin, and oxacillin in human monocytes, and daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus. Antimicrob Agents Chemother 51 (2007) 1559-1562
35. Pfaller M.A., Sader H.S., and Jones R.N. Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005). Diagn Microbiol Infect Dis 57 (2007) 459-465
36. Mortin L.I., Li T., Van Praagh A.D., Zhang S., Zhang X.X., and Alder J.D. Rapid bactericidal activity of daptomycin against MRSA and MSSA peritonitis in mice as measured with bioluminescent bacteria. Antimicrob Agents Chemother 51 (2007) 1787-1794
37. Rybak M.J. The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria. Clin Microbiol Infect 12 suppl. 1 (2006) 24-32
38. Wiedemann B. Test results: characterising the antimicrobial activity of daptomycin. Clin Microbiol Infect 12 suppl. 8 (2006) 9-14
39. Jeu L., and Fung H.B. Daptomycin: a cyclic lipopeptide antimicrobial agent. Clin Ther 26 (2004) 1728-1757